Laman UtamaAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$0.60
Selepas Waktu Dagangan:(4.02%)-0.024
$0.57
Tutup: 2 Apr, 7:58:02 PTG GMT-4 · USD · NYSEAMERICAN · Penafian
Tutup sebelumnya
$0.55
Julat hari
$0.54 - $0.61
Julat tahun
$0.53 - $20.33
Permodalan pasaran
4.85J USD
Bilangan Purata
6.69J
Nisbah P/E
-
Hasil dividen
-
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 21.00K | -53.33% |
Perbelanjaan pengendalian | 2.93J | -50.23% |
Pendapatan bersih | -4.18J | 30.03% |
Margin untung bersih | -19.88K | -49.93% |
Pendapatan bagi setiap syer | -0.44 | 95.60% |
EBITDA | -2.91J | 49.77% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.05J | -23.38% |
Jumlah aset | 5.78J | -32.83% |
Jumlah liabiliti | 15.56J | 56.75% |
Jumlah ekuiti | -9.78J | — |
Syer tertunggak | 8.15J | — |
Harga kepada buku | -0.17 | — |
Pulangan pada aset | -130.90% | — |
Pulangan pada modal | 171.11% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -4.18J | 30.03% |
Tunai daripada operasi | -1.99J | 49.79% |
Tunai daripada pelaburan | -95.00K | -102.56% |
Tunai daripada pembiayaan | 2.72J | 162.20% |
Perubahan bersih dalam tunai | 638.00K | -18.83% |
Aliran tunai bebas | -1.43J | 74.40% |
Perihal
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Diasaskan
1966
Ibu pejabat
Tapak web
Pekerja
22
